We are live on ! Find out more
TNXP icon

Tonix Pharmaceuticals
TNXP

18 hedge funds and large institutions have $51.2M invested in Tonix Pharmaceuticals in 2021 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 4 increasing their positions, 1 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

300% more repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 1

100% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 3

20% more funds holding

Funds holding: 15 → 18 (+3)

0% more ownership

Funds ownership: 0% → 0% (+0%)

40% less capital invested

Capital invested by funds: $85.3M → $51.2M (-$34.1M)

Holders
18
Holders Change
+3
Holders Change %
+20%
% of All Funds
0.32%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
4
Reduced
1
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$4.38M
2
Geode Capital Management
Geode Capital Management
Massachusetts
+$1.46M
3
BlackRock
BlackRock
New York
+$974K
4
State Street
State Street
Massachusetts
+$974K
5
Citadel Advisors
Citadel Advisors
Florida
+$487K

Top Sellers

Rank Fund Capital Flow
1
Norges Bank
Norges Bank
Norway
-$3.06M
2
Renaissance Technologies
Renaissance Technologies
New York
-$974K
3
California State Teachers Retirement System (CalSTRS)
California State Teachers Retirement System (CalSTRS)
California
-$487K
4
Millennium Management
Millennium Management
New York
-$487K
5
ECM
ExodusPoint Capital Management
New York
-$239K
Name Holding Trade Value Shares
Change 		Change in
Stake
IA
76
IFP Advisors
Florida
$1K – – –
NSIM
77
North Star Investment Management
Illinois
$1K – – –
PWM
78
Prentice Wealth Management
New York
$1K – – –
Norges Bank
79
Norges Bank
Norway
– -$3.06M -4 Closed
CAN
80
Cetera Advisor Networks
California
– -$13K – –
CIBC Asset Management
81
CIBC Asset Management
Ontario, Canada
– -$14K – –
ECM
82
ExodusPoint Capital Management
New York
– -$239K – –
FMBTD
83
First Midwest Bank Trust Division
Illinois
– -$28K – –
First Trust Advisors
84
First Trust Advisors
Illinois
– -$192K – –
HighTower Advisors
85
HighTower Advisors
Illinois
– -$23K – –
LCC
86
Lincoln Capital Corp
Rhode Island
– -$11K – –
MIM
87
MetLife Investment Management
New Jersey
– -$150K – –
MLICM
88
Metropolitan Life Insurance Company (MetLife)
New York
– -$115K – –
Nisa Investment Advisors
89
Nisa Investment Advisors
Missouri
– -$46 – –
PAM
90
Panagora Asset Management
Massachusetts
– -$6K – –
PPA
91
Parametric Portfolio Associates
Washington
– -$72K – –
1 2 3
4

TNXP Hedge Fund Activity: Q3 2021 in Review

18 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Tonix Pharmaceuticals (TNXP) for Q3 2021, worth a combined $51.2M — down 40% from $85.3M a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new TNXP positions and 3 closed out — a net gain of 3 holders — while 4 added to existing stakes and 1 trimmed.

The largest buyer was D.E. Shaw & Co, adding an estimated $4.38M. The largest seller was Norges Bank, exiting entirely with an estimated $3.06M sold.

  • 18 institutional investors held Tonix Pharmaceuticals (TNXP) as of Q3 2021, up from 15 in Q2 2021.
  • Funds reported $51.2M of Tonix Pharmaceuticals stock for Q3 2021, down 40% quarter-over-quarter.
  • 6 funds opened new Tonix Pharmaceuticals positions in Q3 2021 and 3 closed out, a net change of +3 holders.
  • The largest Tonix Pharmaceuticals buyer in Q3 2021 was D.E. Shaw & Co, an estimated $4.38M added.
  • The largest Tonix Pharmaceuticals seller in Q3 2021 was Norges Bank, an estimated $3.06M sold.

Based on aggregated 13F filings for Q3 2021.